Literature DB >> 2302838

The affinity of anti-HBc antibodies in acute and chronic hepatitis B infection.

Y M Wen1, S C Duan, C R Howard, A F Frew, M W Steward.   

Abstract

Antibodies to hepatitis B core antigen (anti-HBc) are found in the sera of all individuals infected with hepatitis B virus. A role for these antibodies has been suggested in determining the outcome of infection. In this study, the affinity of anti-HBc antibodies in asymptomatic virus carriers was compared with that of antibodies present in the sera of patients with chronic liver disease. Persistently infected individuals with no evidence of clinical disease were found to have anti-HBc antibodies of greater affinity, compared with the chronic liver disease group. Sera from patients with chronic hepatitis contained high levels of low-affinity antibody whereas antibody levels in asymptomatic carriers were significantly lower. These findings are discussed in relation to the predicted role of anti-HBc antibodies in mediating hepatitis B virus-related hepatocellular injury.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302838      PMCID: PMC1534737          DOI: 10.1111/j.1365-2249.1990.tb05131.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site.

Authors:  D R Milich; A McLachlan; G B Thornton; J L Hughes
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

Review 3.  Antiviral therapy in hepatitis B infection.

Authors:  H C Thomas; L J Scully
Journal:  Br Med Bull       Date:  1985-10       Impact factor: 4.291

4.  Does maternal antibody to core antigen prevent recognition of transplacental transmission of hepatitis-B-virus infection?

Authors:  G J Alexander; A L Eddleston
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  The use of synthetic peptides for analysing the specificity and affinity of anti-HBs antibodies in human sera.

Authors:  S E Brown; C R Howard; A J Zuckerman; M W Steward
Journal:  Ann Sclavo Collana Monogr       Date:  1984

6.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease.

Authors:  A S Lok; P Karayiannis; T P Jowett; M J Fowler; P Farci; J Monjardino; H C Thomas
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

8.  The conversion of hepatitis B core antigen synthesized in E coli into e antigen.

Authors:  P MacKay; J Lees; K Murray
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.

Authors:  S Iwarson; E Tabor; H C Thomas; P Snoy; R J Gerety
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

10.  Hepatitis B virus antigens made in microbial cells immunise against viral infection.

Authors:  K Murray; S A Bruce; A Hinnen; P Wingfield; P M van Erd; A de Reus; H Schellekens
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  6 in total

1.  Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers.

Authors:  S V Beath; E H Boxall; R M Watson; M J Tarlow; D A Kelly
Journal:  BMJ       Date:  1992-05-02

Review 2.  Vaccine therapies for chronic hepatitis B: can we go further?

Authors:  Yumei Wen; Xuanyi Wang; Bin Wang; Zhenhong Yuan
Journal:  Front Med       Date:  2014-01-24       Impact factor: 4.592

3.  The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.

Authors:  D Chargelegue; C M Stanley; C M O'Toole; B T Colvin; M W Steward
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

4.  Low antibody affinity restricted to the IgA isotype in IgA nephropathy.

Authors:  L Layward; A C Allen; J M Hattersley; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

5.  A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.

Authors:  D Chargelegue; C M O'Toole; B T Colvin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Anti-HBc IgG Responses Occurring at the Early Phase of Infection Correlate Negatively with HBV Replication in a Mouse Model.

Authors:  Xuyang Wang; Yumeng Zhang; Yinyin Ben; Chao Qiu; Jing Wu; Wenhong Zhang; Yanmin Wan
Journal:  Viruses       Date:  2022-09-11       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.